Related Experiment Video
Updated: Feb 11, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Using saccades to diagnose covert hepatic encephalopathy
Nicholas Cunniffe1, Henry Munby, Shona Chan
1Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Saccadic latency analysis offers a new diagnostic tool for Covert Hepatic Encephalopathy (CHE) in cirrhosis patients. This objective measure aids early detection, improving patient outcomes and safety.
Area of Science:
- Neuroscience
- Hepatology
- Ophthalmology
Background:
- Covert Hepatic Encephalopathy (CHE), a cognitive deficit in 30-70% of cirrhosis patients, impacts quality of life and survival.
- Current diagnostic methods rely on psychometric tests unsuitable for clinical settings.
- Early diagnosis of CHE is crucial for management and preventing adverse events like impaired driving.
Purpose of the Study:
- To investigate saccadic latency distributions as a viable alternative diagnostic tool for CHE.
- To compare saccadic performance between cirrhosis patients with and without CHE and healthy controls.
- To assess the diagnostic accuracy of saccadic latency analysis for CHE.
Main Methods:
- Collected saccadic latency data from 35 cirrhosis patients and 36 age-matched healthy controls.
- Utilized standard psychometric tests to identify CHE according to World Congress of Gastroenterology criteria.
- Compared visually-evoked saccades and correlated saccadic latencies with biochemical markers and prognostic scores.
Main Results:
- Cirrhosis patients exhibited significantly longer median saccadic latencies than healthy controls.
- Patients with CHE showed significantly prolonged saccadic latencies compared to those without CHE.
- Saccadic latency analysis demonstrated 75% sensitivity and 75% specificity in diagnosing CHE.
Conclusions:
- Saccadic latency distribution analysis is a rapid, objective diagnostic tool for CHE in cirrhosis patients.
- This method facilitates earlier diagnosis, enabling timely interventions and risk mitigation (e.g., driving).
- Improved early detection can enhance treatment strategies and patient management for CHE.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters

